Vista Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Vista Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$360K	Sell	5,777 -9	-0.2%	-$569	0.09%	130
2026 Q2	$333K	Sell	5,786 -55	-0.9%	-$3.16K	0.08%	138
2026 Q1	$354K	Buy	5,841 +14	+0.2%	+$816	0.09%	133
2025 Q4	$314K	Buy	5,827 +470	+9%	+$22.6K	0.08%	136
2025 Q3	$242K	Buy	5,357 +11	+0.2%	+$514	0.07%	145
2025 Q2	$247K	Sell	5,346 -56	-1%	-$2.75K	0.07%	141
2025 Q1	$329K	Buy	5,402 +157	+3%	+$9.15K	0.1%	133
2024 Q4	$297K	Sell	5,245 -294	-5%	-$16.4K	0.09%	135
2024 Q3	$287K	Buy	5,539 +10	+0.2%	+$469	0.09%	129
2024 Q2	$230K	Sell	5,529 -23,443	-81%	-$1.05M	0.08%	141
2024 Q1	$1.57M	Sell	28,972 -724	-2%	-$36.9K	0.53%	57
2023 Q4	$1.52M	Buy	+29,696	New	+$1.56M	0.56%	57

Other funds holding BMY

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vista Investment Partners's BMY Position: Q3 2026 in Review

Vista Investment Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.16% in Q3 2026, selling an estimated $569 and leaving 5,777 shares worth $360K. The position accounts for 0.09% of the portfolio, ranked #130.

Vista Investment Partners first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.57M in Q1 2024. 404 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Vista Investment Partners held 5,777 shares of Bristol-Myers Squibb worth $360K as of Q3 2026.
Vista Investment Partners sold 9 Bristol-Myers Squibb shares in Q3 2026, an estimated $569.
Bristol-Myers Squibb made up 0.09% of Vista Investment Partners's portfolio in Q3 2026, its #130 holding.
Vista Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
Vista Investment Partners's Bristol-Myers Squibb position peaked at $1.57M in Q1 2024.
404 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Vista Investment Partners's 13F filing for Q3 2026, filed 8 Oct 2026.